Test Price
2,800 AED✅ Home Collection Available
RET Gene Multiple Endocrine Neoplasia Type 2A Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM–11 PM, daily).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation with our DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This definitive Genetic Test interrogates the entire RET proto-oncogene for germline mutations that cause Multiple Endocrine Neoplasia type 2A (MEN2A). It provides actionable insight into lifetime risk for medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism, empowering early surveillance and prophylactic interventions.
| Feature | Our RET MEN2A NGS Test | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) – full gene coverage | Sanger sequencing of hot-spot exons only |
| Detection Rate | >99.9% of known pathogenic variants in coding regions ±10 bp | ~95% for common point mutations; misses large deletions/duplications |
| Turnaround Time | 3 – 4 Weeks | 2 – 3 Weeks |
| Clinical Utility | Comprehensive – includes rare variants, copy number changes, and VUS interpretation | Limited – may require reflex to full NGS |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403, Consultant Medical Genetics) notes: “A positive RET mutation is a lifelong risk marker, not a cancer diagnosis. It demands expert interpretation, genetic counselling, and personalized surveillance. Always correlate with clinical findings and family history. Never discontinue prescribed medication without consulting your doctor.”
Medication Advisory
Do not discontinue any prescribed medication, especially antihypertensives or thyroid hormone replacement, without prior consultation with your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Minors under 18 years without court‑approved guardian consent (UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability). Patients with active psychiatric crisis unable to provide informed consent.
- ER Red Flags (seek immediate care): Sudden severe headache, palpitations, sweating, and dangerously high blood pressure (possible pheochromocytoma crisis). Rapidly enlarging neck mass or hoarseness (potential medullary thyroid carcinoma progression).
Patient FAQ & Clinical Guidance
1. What is the RET MEN2A NGS test and why is it done?
This test sequences the entire RET gene to identify inherited mutations causing MEN2A, enabling proactive cancer screening and risk‑reduction strategies.
2. How is the sample collected and what is the turnaround time?
A simple blood draw is collected by our VIP Mobile Phlebotomy team; results are reported within 3 to 4 weeks.
3. Is this test covered by insurance in the UAE?
Many UAE insurers cover genetic testing for hereditary cancer syndromes when medically indicated; we verify benefits instantly via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
All genetic data handling and processing comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (INT/EGQ/2509DA/3139) and operates under DHA/MOHAP standards.
Clinical & Logistical Metadata
| Test Name | RET Gene Multiple Endocrine Neoplasia Type 2A Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage including coding regions and splice sites |
| ICD‑10‑CM Code | Z15.89 |
| LOINC Code | 21698-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians